Targeted Inhibition of AKT in Pancreatic Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|5|4|288-295

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.4, 2009-01, pp. : 288-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 6, 2005-11 ,pp. : 575-589

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 1, 2016-01 ,pp. : 29-37

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway

By Yao Jun   Qian Cuijuan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 1017-1022

Humana Press, Inc

Access to resources Recommend Favorite

Pancreatic cancer — Outlook: targeted therapy

By Michl Patrick   Gress Thomas  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 176-180

Springer Publishing Company

Access to resources Recommend Favorite

Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway

By          

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5415-5422

Spandidos Publications

Access to resources Recommend Favorite